SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 80 filers reported holding SYNERON MEDICAL LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $9,633,000 | -44.5% | 879,740 | -46.5% | 0.56% | -43.3% |
| Q1 2017 | $17,355,000 | +15.7% | 1,645,048 | -7.9% | 0.99% | +12.8% |
| Q4 2016 | $15,001,000 | +35.2% | 1,785,826 | +15.2% | 0.88% | +21.3% |
| Q3 2016 | $11,098,000 | -13.5% | 1,550,006 | -7.1% | 0.72% | -9.2% |
| Q2 2016 | $12,829,000 | -2.3% | 1,668,307 | -7.2% | 0.80% | -2.1% |
| Q1 2016 | $13,136,000 | -6.0% | 1,796,969 | -0.9% | 0.81% | +1.2% |
| Q4 2015 | $13,977,000 | +32.7% | 1,812,895 | +23.0% | 0.80% | +35.5% |
| Q3 2015 | $10,536,000 | -13.3% | 1,473,613 | +28.8% | 0.59% | -5.9% |
| Q2 2015 | $12,155,000 | +2.6% | 1,144,504 | +19.6% | 0.63% | -5.3% |
| Q1 2015 | $11,842,000 | +32.0% | 956,581 | -0.5% | 0.66% | +34.1% |
| Q4 2014 | $8,974,000 | +13.3% | 961,831 | +21.7% | 0.50% | +10.2% |
| Q3 2014 | $7,919,000 | – | 790,288 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |